Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy

United nations scientific committee on the effects of atomic radiation (UNSCEAR). Epidemiological studies of radiation and cancer. Effects of ionising radiation Vol I, Annex A. 2006; Vienna, Austria.

Newhauser, 2011, Assessing the risk of second malignancies after modern radiotherapy, Nat Rev Cancer, 11, 438, 10.1038/nrc3069

Brenner, 2000, Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery, Cancer, 88, 398, 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V

Sachs, 2005, Solid tumor risks after high doses of ionizing radiation, Proc Natl Acad Sci USA, 102, 13040, 10.1073/pnas.0506648102

Travis, 1997, Risk of second malignant neoplasms among long-term survivors of testicular cancer, J Natl Cancer Inst, 89, 1429, 10.1093/jnci/89.19.1429

Meadows, 2009, Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort, J Clin Oncol, 27, 2356, 10.1200/JCO.2008.21.1920

Paganetti, 2012, Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field, Phys Med Biol, 57, 6047, 10.1088/0031-9155/57/19/6047

Schneider, 2015, The impact of neutrons in clinical proton therapy, Front Oncol, 5, 235, 10.3389/fonc.2015.00235

Schneider, 2005, Radiation risk estimates after radiotherapy: application of the organ equivalent dose concept to plateau dose-response relationships, Radiat Environ Biophys, 44, 235, 10.1007/s00411-005-0016-1

Schneider, 2011, Modeling the risk of secondary malignancies after radiotherapy, Genes, 2, 1033, 10.3390/genes2041033

Schneider, 2005, Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose, Int J Radiat Oncol Biol Phys, 61, 1510, 10.1016/j.ijrobp.2004.12.040

Daşu, 2011, Secondary malignancies from prostate cancer radiation treatment: a risk analysis of the influence of target margins and fractionation patterns, Int J Radiat Oncol Biol Phys, 79, 738, 10.1016/j.ijrobp.2009.12.004

Daşu, 2005, The use of risk estimation models for the induction of secondary cancers following radiotherapy, Acta Oncol, 44, 339, 10.1080/02841860510029833

Loeffler, 2013, Charged particle therapy–optimization, challenges and future directions, Nat Rev Clin Oncol, 10, 411, 10.1038/nrclinonc.2013.79

Eaton, 2015, Secondary malignancy risk following proton radiation therapy, Front Oncol, 5, 261, 10.3389/fonc.2015.00261

Doyen, 2016, Proton beams in cancer treatments: clinical outcomes and dosimetric comparisons with photon therapy, Cancer Treat Rev, 43, 104, 10.1016/j.ctrv.2015.12.007

Yock, 2012, Risk of second cancers after photon and proton radiotherapy: a review of the data, Health Phys, 103, 577, 10.1097/HP.0b013e3182609ba4

Combs, 2012, Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data, Radiat Oncol, 7, 170, 10.1186/1748-717X-7-170

Newhauser, 2016, Review of radiotherapy-induced late effects research after advanced technology treatments, Front Oncol, 6, 13, 10.3389/fonc.2016.00013

Shuryak, 2009, A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation, Radiat Environ Biophys, 48, 275, 10.1007/s00411-009-0231-2

Rechner, 2015, Risk-optimized proton therapy to minimize radiogenic second cancers, Phys Med Biol, 60, 3999, 10.1088/0031-9155/60/10/3999

Stokkevåg, 2015, Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer, Acta Oncol, 54, 1317, 10.3109/0284186X.2015.1061691

Ardenfors, 2014, Are IMRT treatments in the head and neck region increasing the risk of secondary cancers?, Acta Oncol, 53, 1041, 10.3109/0284186X.2014.925581

Stokkevåg, 2014, Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy, Acta Oncol, 53, 1048, 10.3109/0284186X.2014.928420

Brodin, 2011, Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma, Acta Oncol, 50, 806, 10.3109/0284186X.2011.582514

Nguyen, 2015, Assessment of uncertainties in radiation-induced cancer risk predictions at clinically relevant doses, Med Phys, 42, 81, 10.1118/1.4903272

Fontenot, 2010, Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy, Phys Med Biol, 55, 6987, 10.1088/0031-9155/55/23/S02

Newhauser, 2015, The physics of proton therapy, Phys Med Biol, 60, R155, 10.1088/0031-9155/60/8/R155

Schardt, 2010, Heavy-ion tumor therapy: physical and radiobiological benefits, Rev Mod Phys, 82

Ando, 2009, Biological characteristics of carbon-ion therapy, Int J Radiat Biol, 85, 715, 10.1080/09553000903072470

Paganetti, 2015, Relating proton treatments to photon treatments via the relative biological effectiveness-should we revise current clinical practice?, Int J Radiat Oncol Biol Phys, 91, 892, 10.1016/j.ijrobp.2014.11.021

Sorensen, 2011, In vitro RBE-LET dependence for multiple particle types, Acta Oncol, 50, 757, 10.3109/0284186X.2011.582518

Rorvik, 2017, A phenomenological biological dose model for proton therapy based on linear energy transfer spectra, Med Phys, 10.1002/mp.12216

Furusawa, 2000, Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Ne-ion beams, Radiat Res, 154, 485, 10.1667/0033-7587(2000)154[0485:IOAAHC]2.0.CO;2

International Commission on Radiation Units and Measurements (ICRU). Prescribing, recording, and reporting proton beam therapy. Report No. 78. J ICRU. 2007; Bethesda, MD, US.

Wedenberg, 2014, Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans, Med Phys, 41, 091706, 10.1118/1.4892930

Molinelli, 2016, Dose prescription in carbon ion radiotherapy: how to compare two different RBE-weighted dose calculation systems, Radiother Oncol, 120, 307, 10.1016/j.radonc.2016.05.031

Fossati, 2012, Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy, Phys Med Biol, 57, 7543, 10.1088/0031-9155/57/22/7543

Girdhani, 2013, Biological effects of proton radiation: what we know and don't know, Radiat Res, 179, 257, 10.1667/RR2839.1

Tommasino, 2015, Proton radiobiology, Cancers, 7, 353, 10.3390/cancers7010353

Girdhani, 2015, Biological effects of proton radiation: an update, Radiat Prot Dosimetry, 166, 334, 10.1093/rpd/ncv178

Bekelman, 2013, Subsequent malignancies after photon versus proton radiation therapy, Int J Radiat Oncol Biol Phys, 87, 10, 10.1016/j.ijrobp.2013.05.016

Particle Therapy Co-Operative Group (PTCOG). Facilities in operation 2016. Available from: http://ptcog.ch. [accessed 01.02.17].

Ebner, 2016, The Emerging Role of Carbon-Ion Radiotherapy, Front Oncol, 6, 140, 10.3389/fonc.2016.00140

Schlaff, 2014, Bringing the heavy: carbon ion therapy in the radiobiological and clinical context, Radiat Oncol, 9, 88, 10.1186/1748-717X-9-88

Kamada, 2015, Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience, Lancet Oncol, 16, e93, 10.1016/S1470-2045(14)70412-7

Durante, 2008, Heavy ion carcinogenesis and human space exploration, Nat Rev Cancer, 8, 465, 10.1038/nrc2391

Little, 2000, Radiation carcinogenesis, Carcinogenesis, 21, 397, 10.1093/carcin/21.3.397

Schipler, 2013, DNA double-strand-break complexity levels and their possible contributions to the probability for error-prone processing and repair pathway choice, Nucleic Acids Res, 41, 7589, 10.1093/nar/gkt556

Jackson, 2002, Sensing and repairing DNA double-strand breaks, Carcinogenesis, 23, 687, 10.1093/carcin/23.5.687

Suzuki, 1996, LET dependence of cell death, mutation induction and chromatin damage in human cells irradiated with accelerated carbon ions, Adv Space Res, 18, 127, 10.1016/0273-1177(95)00799-K

Suit, 2007, Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects, Radiat Res, 167, 12, 10.1667/RR0527.1

Durante, 2014, New challenges in high-energy particle radiobiology, Br J Radiol, 1035, 20130626, 10.1259/bjr.20130626

Yatagai, 2004, Mutations induced by heavy charged particles, Biol Sci Space, 18, 224, 10.2187/bss.18.224

Suzuki, 2003, Qualitative and quantitative difference in mutation induction between carbon- and neon-ion beams in normal human cells, Biol Sci Space, 17, 302, 10.2187/bss.17.302

Stoll, 1995, Killing and mutation of Chinese hamster V79 cells exposed to accelerated oxygen and neon ions, Radiat Res, 142, 288, 10.2307/3579138

George, 2015, Biological Effectiveness of Accelerated Protons for Chromosome Exchanges, Front Oncol, 5, 226, 10.3389/fonc.2015.00226

Britten, 2013, Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam, Radiat Res, 179, 21, 10.1667/RR2737.1

Durante, 2000, X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes, Int J Radiat Oncol Biol Phys, 47, 793, 10.1016/S0360-3016(00)00455-7

Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37:1–332.

Engels, 1999, Risk assessment for cancer induction after low- and high-LET therapeutic irradiation, Strahlenther Onkol, 175, 47, 10.1007/BF03038888

Braunstein, 2013, Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk, Front Oncol, 3, 73, 10.3389/fonc.2013.00073

Jones, 2009, Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions, J Radiol Prot, 29, 10.1088/0952-4746/29/2A/S10

Eley, 2016, Comparative risk predictions of second cancers after carbon-ion therapy versus proton therapy, Int J Radiat Oncol Biol Phys, 95, 279, 10.1016/j.ijrobp.2016.02.032

Stokkevåg, 2016, Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy, Radiother Oncol, 120, 300, 10.1016/j.radonc.2016.07.001

Manem, 2015, The effect of radiation quality on the risks of second malignancies, Int J Radiat Biol, 91, 209, 10.3109/09553002.2014.980466

Committee to Assess Health Risks from Exposure to Low Level of Ionizing Radiation. Board on Radiation Effects Research (BEIR VII) report, Washington DC, US: National Academies Press; 2006.

Brenner, 2004, Estimated radiation risks potentially associated with full-body CT screening, Radiology, 232, 735, 10.1148/radiol.2323031095

Taddei, 2009, Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams, Phys Med Biol, 54, 2259, 10.1088/0031-9155/54/8/001

Schneider, 2006, The impact of IMRT and proton radiotherapy on secondary cancer incidence, Strahlenther Onkol, 182, 647, 10.1007/s00066-006-1534-8

Hall, 2006, Intensity-modulated radiation therapy, protons, and the risk of second cancers, Int J Radiat Oncol Biol Phys, 65, 1, 10.1016/j.ijrobp.2006.01.027

Schneider, 2002, Secondary neutron dose during proton therapy using spot scanning, Int J Radiat Oncol Biol Phys, 53, 244, 10.1016/S0360-3016(01)02826-7

Newhauser, 2009, Contemporary proton therapy systems adequately protect patients from exposure to stray radiation, AIP Conf Proc, 1099, 450, 10.1063/1.3120071

Homann, 2015, The need for individualized studies to compare radiogenic second cancer (RSC) risk in proton versus photon Hodgkin Lymphoma patient treatments, J Proton Therapy, 1, 1